Is FDA dissolution database more preferable to product specific FDA BE guidance? [Dissolution / BCS / IVIVC]

posted by Vineeth KE – India, 2019-04-25 11:15  – Posting: # 20229
Views: 439

» For a Oral solid dosage form [tablet and suspension], FDA dissolution database is recommending dissolution to be done at 25 degrees whereas, product specific FDA guidance for the same product is mentioning 37 degrees.
»
» Which temperature should i need to adapt and follow for generic development ?

For development purpose, it is advisable to follow 37 degrees, as it mimics in-vivo condition (For oral solid dosage form).

If the drug release is affected by temperature (due to API solubility/Surfactant Solubility in dissolution media/API degradation/gelling of excipients or any other reasons), it is better to consider the worst case scenario (25 or 37degrees).

For submission purpose, we need to evaluate in both the conditions as mentioned in FDA-Dissolution database & FDA-Product specific guidance.

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,687 posts in 4,178 threads, 1,352 registered users;
online 8 (0 registered, 8 guests [including 3 identified bots]).
Forum time (Europe/Vienna): 18:33 UTC

The fundamental cause of trouble in the world today is
that the stupid are cocksure
while the intelligent are full of doubt.    Bertrand Russell

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5